Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2026-02-20 @ 6:41 PM
Study NCT ID:
NCT00279435
Status:
TERMINATED
Last Update Posted:
2012-03-12
First Post:
2006-01-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study
Sponsor:
Facet Biotech
Organization: